- Student Records
Programme & Unit Catalogues


PA30148: Central nervous system pharmacology

Follow this link for further information on academic years Academic Year: 2015/6
Further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Further information on credits Credits: 6
Further information on unit levels Level: Honours (FHEQ level 6)
Further information on teaching periods Period: Semester 2
Further information on unit assessment Assessment Summary: EX 100%
Further information on unit assessment Assessment Detail:
  • Examination (EX 100%)
Further information on supplementary assessment Supplementary Assessment: Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites:
Further information on descriptions Description: Aims:
The aim of this unit is to provide a knowledge base of recent developments in central nervous system (CNS) pharmacology. In this unit, the broad base of CNS pharmacology obtained in earlier units (PA20023) will be the basis for an in depth study of selected topics. The aim will be to develop a knowledge and understanding of the neurophysiological and neuroanatomical basis of behaviours, and how such knowledge can be exploited for the identification and development of novel drug targets.

Learning Outcomes:
On successful completion of this unit, the student should be able to: demonstrate knowledge and understanding of recently identified target molecules and processes in the CNS, give examples of the role of these targets in particular therapeutic areas and utilise a range of ICT and cognitive skills in acquiring knowledge and understanding and applying them to given situations.

Skills:
Scientific skills (T/F/A)
Study skills, handling information, working with others (T/F).

Content:
A number of topics will be discussed in depth. In general, a knowledge of the neurobiology of a behaviour, that when perturbed can lead to clinical conditions, will be coupled with a detailed understanding of the molecular mechanisms involved. In this way a rationale for identifying novel targets for therapeutics will emerge. Topics will be selected on the basis of their currency at a given time - examples may include anxiety pathways and novel anxiolytics, reward pathways and novel treatments for drug addiction.
Further information on programme availabilityProgramme availability:

PA30148 is Optional on the following programmes:

Programmes in Natural Sciences
  • UXXX-AFB01 : BSc(Hons) Natural Sciences (Year 3)
  • UXXX-AAB02 : BSc(Hons) Natural Sciences with Study year abroad (Year 4)
  • UXXX-AKB02 : BSc(Hons) Natural Sciences with Year long work placement (Year 4)
  • UXXX-AFM01 : MSci(Hons) Natural Sciences (Year 3)
  • UXXX-AKM02 : MSci(Hons) Natural Sciences with Professional Placement (Year 4)
  • UXXX-AAM02 : MSci(Hons) Natural Sciences with Study year abroad (Year 4)
Department of Pharmacy & Pharmacology
  • USPA-AFB02 : BSc(Hons) Pharmacology (Year 3)
  • USPA-AKB02 : BSc(Hons) Pharmacology with Year long work placement (Year 4)

Notes:
* This unit catalogue is applicable for the 2015/16 academic year only. Students continuing their studies into 2016/17 and beyond should not assume that this unit will be available in future years in the format displayed here for 2015/16.
* Programmes and units are subject to change at any time, in accordance with normal University procedures.
* Availability of units will be subject to constraints such as staff availability, minimum and maximum group sizes, and timetabling factors as well as a student's ability to meet any pre-requisite rules.